Triaptosis-based therapeutic innovations could offer renewed hope for cancer patients
Cancer remains one of the most critical global public health challenges, exerting profound social, economic, and clinical burdens…
Stereotactic radiosurgery for craniopharyngioma management
Craniopharyngiomas account for 2–5% of all primary brain tumors and 5–10% of pediatric brain tumors. Despite their benign…
New NIH grants fuel research in oral cancer treatment and pain relief
Researchers at the School of Dentistry at UT Health San Antonio, the academic health center of The University…
Early trial finds promise for avelumab and radiation in treating leptomeningeal disease
Researchers at Moffitt Cancer Center have reported encouraging results from a phase 1B clinical trial showing that the…
Randomized trial finds both proton and photon therapies preserve post-treatment well-being
The first randomized trial to compare photon- and proton-based radiation therapy for breast cancer finds that patients report…
Can high-protein supplements improve cancer recovery?
New evidence reveals that protein-rich oral supplements can support cancer recovery with fewer complications and shorter hospital stays,…
Insights into the clinical presentation and management of sellar chondrosarcomas
Chondrosarcomas are a malignant form of bone cancer that is composed of cartilage-forming tumor cells. Sellar chondrosarcomas, which…
PSMA PET/CT improves outcomes for men with recurrent prostate cancer
A new study from Denmark shows for the first time that men with biochemically recurrent prostate cancer who…